Judy Shi

782 total citations
8 papers, 202 citations indexed

About

Judy Shi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Judy Shi has authored 8 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Genetics. Recurrent topics in Judy Shi's work include Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Judy Shi is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Judy Shi collaborates with scholars based in United States, China and Japan. Judy Shi's co-authors include Julia H. Kaufman, Sarah Ryan, Ruicong She, Joel B. Greenhouse, Marc L. Hyer, Vaishali Shinde, Doug Bowman, Natalie Roy D’Amore, Bradley Stringer and Denise L. Driscoll and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Judy Shi

7 papers receiving 195 citations

Peers

Countries citing papers authored by Judy Shi

Since Specialization

Citations

This map shows the geographic impact of Judy Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Shi more than expected).

Fields of papers citing papers by Judy Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Shi. The network helps show where Judy Shi may publish in the future.

Co-authorship network of co-authors of Judy Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Shi. A scholar is included among the top collaborators of Judy Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Shi. Judy Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy 2022 ·Cancer Immunology Immunotherapy ·Yosuke Sato, Cierra N. Casson, Atsushi Matsuda, James I. Kim, Judy Shi, Shinji Iwasaki, Susan Chen, Brett Modrell, Ching-Kit Chan, (unknown), Douglas Austen, (unknown), Olga Tayber, (unknown), (unknown), Yafang Lin, Michael H. Shaw	20
2	Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma 2019 ·Blood ·Junling Zhuang, Fazal Shirazi, Ramesh Singh, Isere Kuiatse, Hua Wang, Hans C. Lee, Zuzana Berkova, Allison Berger, Marc L. Hyer, Nibedita Chattopadhyay, (unknown), Judy Shi, Jie Yu, Vaishali Shinde, Stephen Tirrell, Richard J. Jones, Zhiqiang Wang, R. Eric Davis, Robert Z. Orlowski	57
3	Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles 2017 ·Xenobiotica ·Pujiang Shi, Mingxiang Liao, (unknown), Robert Griffin, Judy Shi, Marc L. Hyer, John K. Fallon, Philip C. Smith, Chao Li, Cindy Q. Xia	8
4	The Anti-Tumor Effect of the Ubiquitin-Activating Enzyme (UAE) Inhibitor TAK-243 on Pre-Clinical Models of Multiple Myeloma 2016 ·Blood ·Junling Zhuang, Hans C. Lee, Isere Kuiatse, Hua Wang, Fazal Shirazi, Allison Berger, Marc L. Hyer, Nibedita Chattopadhyay, (unknown), Judy Shi, Jie Yu, Vaishali Shinde, (unknown), Stephen Tirrell, Saurabh Menon, Richard J. Jones, Robert Z. Orlowski	4
5	The effectiveness of blended online learning courses at the community college level 2015 ·Community College Journal of Research and Practice ·Sarah Ryan, Julia H. Kaufman, Joel B. Greenhouse, Ruicong She, Judy Shi	67
6	Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines 2014 ·PLoS ONE ·Denise L. Driscoll, Arijit Chakravarty, Doug Bowman, Vaishali Shinde, (unknown), Judy Shi, Tricia J. Vos, Bradley Stringer, (unknown), Natalie Roy D’Amore, Marc L. Hyer	45
7	231 Clinical pharmacodynamic assay development for the first in class investigational ubiquitin activating enzyme (UAE) inhibitor MLN7243 2014 ·European Journal of Cancer ·Brittany Bahamón, Feng Gao, B. M. J. Stringer, Yong Yang, Judy Shi, Kristine Burke, Jessica J. Huck, Tary Traore, Doug Bowman, Hadi Danaee, (unknown), Marc L. Hyer, Neil Bence, (unknown)	1
8	Abstract 3573: A small molecule PLK1 inhibitor, MLN0905, yields broad anti-tumor activity in human xenograft tumor models, and synergizes with taxane therapy 2011 ·Cancer Research ·(unknown), Judy Shi, Vaishali Shinde, Bradley Stringer, Mark G. Qian, (unknown), Ray Liu, Matthew O. Duffey, Tricia J. Vos, Natalie Roy D’Amore, Marc L. Hyer, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact